Bender Robert & Associates Bristol Myers Squibb CO Transaction History

Bender Robert & Associates

$471 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$47.98 - $54.4 $11,995 - $13,600	-250 Reduced 0.9%	27,442 $1.49 Million
Q4 2023 Jan 31, 2024	SELL	$48.48 - $57.85 $242 - $289	-5 Reduced 0.02%	27,692 $1.42 Million
Q3 2023 Oct 13, 2023	SELL	$57.89 - $64.73 $34,734 - $38,838	-600 Reduced 2.12%	27,697 $1.61 Million
Q2 2023 Jul 13, 2023	BUY	$63.71 - $70.74 $26,121 - $29,003	410 Added 1.47%	28,297 $1.81 Million
Q1 2023 Apr 20, 2023	SELL	$65.71 - $74.53 $3,942 - $4,471	-60 Reduced 0.21%	27,887 $1.93 Million
Q3 2022 Oct 26, 2022	BUY	$0.13 - $76.84 $375 - $221,683	2,885 Added 11.51%	27,947 $1.99 Million
Q2 2022 Jul 19, 2022	SELL	$72.62 - $79.98 $21,786 - $23,994	-300 Reduced 1.18%	25,062 $1.93 Million
Q1 2022 Apr 14, 2022	BUY	$61.48 - $73.72 $610,926 - $732,555	9,937 Added 64.42%	25,362 $1.85 Million
Q3 2021 Nov 03, 2021	BUY	$59.17 - $69.31 $3,905 - $4,574	66 Added 0.43%	15,425 $913,000
Q2 2021 Jul 16, 2021	BUY	$61.91 - $67.42 $97,817 - $106,523	1,580 Added 11.47%	15,359 $1.03 Million
Q1 2021 Apr 28, 2021	BUY	$59.34 - $66.74 $50,498 - $56,795	851 Added 6.58%	13,779 $870,000
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $57 - $65	1 Added 0.01%	12,928 $802,000
Q3 2020 Oct 29, 2020	BUY	$57.43 - $63.64 $11,543 - $12,791	201 Added 1.58%	12,927 $779,000
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $140,339 - $164,070	2,560 Added 25.18%	12,726 $748,000
Q1 2020 Apr 21, 2020	SELL	$46.4 - $67.43 $1,809 - $2,629	-39 Reduced 0.38%	10,166 $567,000
Q4 2019 Jan 31, 2020	SELL	$49.21 - $64.19 $7,873 - $10,270	-160 Reduced 1.54%	10,205 $655,000
Q3 2019 Oct 15, 2019	SELL	$42.77 - $50.71 $19,973 - $23,681	-467 Reduced 4.31%	10,365 $526,000
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $37,436 - $41,396	-839 Reduced 7.19%	10,832 $491,000
Q1 2019 Apr 30, 2019	SELL	$45.12 - $53.8 $4,512 - $5,380	-100 Reduced 0.85%	11,671 $557,000
Q4 2018 Jan 24, 2019	SELL	$48.76 - $63.23 $19,942 - $25,861	-409 Reduced 3.36%	11,771 $612,000
Q2 2018 Jul 27, 2018	SELL	$50.53 - $62.98 $19,656 - $24,499	-389 Reduced 3.09%	12,180 $674,000
Q1 2018 Apr 27, 2018	SELL	$59.92 - $68.98 $6,591 - $7,587	-110 Reduced 0.87%	12,569 $795,000
Q4 2017 Jan 19, 2018	SELL	$59.94 - $65.35 $19,420 - $21,173	-324 Reduced 2.49%	12,679 $777,000
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $718,155 - $828,811	13,003	13,003 $829,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Bender Robert & Associates with notifications on news.

Account